arrow
J

Jaime Kulisevsky

Sant Pau Hospital
H指数:75
被引数:3.5万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Neurofilament Light Chain and Mutant Huntingtin Across Huntington's Disease Integrated Staging System Stages in Huntington Disease: A Cross‐Sectional Multimodal Analysis

神经丝轻链和突变亨廷顿蛋白在亨廷顿病整合分期系统各阶段中的横断面多模态分析

2026-10-140
OA
Association of α-synuclein seed-amplification kinetics with cognitive decline in idiopathic Parkinson's disease

α-突触核蛋白种子扩增动力学与特发性帕金森病认知衰退的关联

2026-07-010
PRE
Spontaneous speech and language measures as predictive biomarkers of clinically meaningful disease progression and neurodegeneration in Huntington’s disease

自发性言语和语言指标作为预测亨廷顿病临床显著疾病进展和神经退行性变的生物标志物

2026-03-310
OAAI
Early start of opicapone in Parkinson’s disease: evidence from a pooled analysis of phase 3 trials for sustained benefit in patients with recent onset of motor fluctuations

帕金森病中奥匹卡朋的早期开始:来自一项合并分析的证据,该分析基于3期试验,表明对于近期出现运动波动的患者具有持续获益。

2025-12-150
OAAI
Brain-derived extracellular vesicle proteomics reveals neuroprotection induced by the ARB candesartan in Parkinson’s disease patients

脑源性细胞外囊泡蛋白质组学揭示血管紧张素II受体拮抗剂坎地沙坦在帕金森病患者中诱导的神经保护作用

2025-12-100
OAAI
Consolidation deficits in episodic memory define distinct clinical and neurodegenerative profiles in Huntington’s disease

情景记忆巩固缺陷在亨廷顿病中定义了独特的临床和神经退行性特征。

2025-10-280
OAAI
Alterations of NMDAR Subunits in the Cerebrospinal Fluid Across Neurodegenerative and Immunological Disorders

脑脊液中NMDAR亚基在神经退行性疾病和免疫性紊乱中的改变

2025-08-180
OAAI
Expanding the clinical–radiological phenotype of SCA34 and its role in the differential diagnosis of the hot cross bun sign

扩展SCA34的临床-放射学表型及其在热十字面包征鉴别诊断中的作用

2025-08-110
PRE